Evaluation of GAS8-AS1 Long Non-Coding RNA and GAS8 Target Gene Expression in Patients with Multiple Sclerosis
Subject Areas : Journal of Animal BiologyMona Patoughi 1 , Soudeh Ghafouri-Fard 2 *
1 - Science and Research Branch, Islamic Azad University, Tehran, Iran
2 - Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Keywords: Gene expression, Multiple Sclerosis, GAS8, GAS8-AS1,
Abstract :
Expression of the growth arrest specific 8 (GAS8) and its naturally occurring antisense RNA (asRNA) (GAS8-AS1) was assessed in tumoral tissues of different origins. However, their association with immune-related disorders has been poorly understood. In the current study, we evaluated the expression levels of these genes in 50 relapsing remitting multiple sclerosis (RRMS) patients compared with age and sex matched control. Expression assays were performed on peripheral blood samples of study participants following extraction of total RNA and cDNA synthesis using blood. Measurements were then made using the TaqMan (Real Time PCR) method with specific primers and probes sequences. Expression of both genes was significantly higher compared to controls (P=0.001 and p
1. Achiron A., Feldman A., Mandel M., Gurevich M. 2007. Impaired Expression of Peripheral Blood Apoptotic‐Related Gene Transcripts in Acute Multiple Sclerosis Relapse. Annals of the New York Academy of Sciences, 1107(1): 155-167.
2. Colantonio J.R., Vermot J., Wu D., Langenbacher A.D., Fraser S., Chen J.N. 2009. The dynein regulatory complex is required for ciliary motility and otolith biogenesis in the inner ear. Nature, 457(7226): 205-102.
3. Gironi M., Bergami A., Brambilla E., 2016. Immunological markers in multiple sclerosis. Neurological Sciences, 21(2): S871
4. Imamura K., Akimitsu N. 2014. Long non-coding RNAs involved in immune responses. Frontiers in Immunology, 5: 573.
5. Kurtzke J.F. 1983. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology, 33: 1444-1452.
6. Lazarou M., Narendra D.P., Jin S.M., Tekle E., Banerjee S., Youle R..J. 2013. PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. Journal of Cell Biology, 200(2): 163-172.
7. Milo R., Kahana E. 2010. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmunity Reviews, 9(5): A387-A94.
8. Qin Y., Sun W., Zhang H., Zhang P., Wang Z., Dong W. 2018. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Endocrine, 59(3):555-64.
9. Satoh J.I., Nakanishi M., Koike F., Miyake S., Yamamoto T., Kawai M. 2005. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiology of Disease, 18(3): 537-550
10. Solomon A.J., Klein E.P., Bourdette D. 2012. "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology, 78(24):1986-1991.
11. van Kester M.S., Borg M. K., Zoutman W.H., Out-Luiting J.J., Jansen P.M., Dreef, E.J., Vermeer M.H., van Doorn R., Willemze R., Tensen C.P. 2012. A Meta-Analysis of Gene Expression Data Identifies a Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides, Journal of Investigative Dermatology, 132(8):2050-2059.
12. Whitmore S.A., Settasatian C., Crawford J., Lower K.M., McCallum B., Seshadri R. 1998. Characterization and Screening for Mutations of the Growth Arrest-Specific 11 (GAS11) andC16orf3Genes at 16q24. 3 in Breast Cancer. Genomics, 52(3): 325-331.
13. Zozulya A.L., Wiendl H. 2008. The role of regulatory T cells in multiple sclerosis. Nature Reviews of Neurology, 4(7): 384.